|
|
|
|
Kyverna Therapeutics Inc (NASDAQ: KYTX) |
|
|
|
| |
Kyverna Therapeutics Inc 's Long Term Debt to Equity
KYTX's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth
|
Select the Comparisons :
|
|
Select the Ratio:
|
Long Term Debt to Equity ▼
|
Long Term Debt to Equity ▼
|
| KYTX Long Term Debt to Equity |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Equity Change |
-37.95 % |
- |
- |
- |
- |
| Y / Y Long Term Debt Change |
- |
- |
- |
- |
- |
| Long Term Debt to Equity MRQ |
- |
- |
- |
- |
- |
| KYTX's Total
Ranking |
# |
# |
# |
# |
# |
| Seq. Equity Change |
-15.97 % |
-11.93 % |
-9.23 % |
-7.61 % |
- |
| Seq. Long Term Debt Change |
- |
- |
- |
- |
- |
| Long Term Debt to Equity first quarter 2025 Company Ranking |
| Within: |
No. |
| Biotechnology & Pharmaceuticals Industry |
# |
| Healthcare Sector |
# |
| Overall Market |
# |
| Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 |
|
|
|
Cumulative Kyverna Therapeutics Inc 's Long Term Debt to Equity
KYTX's Long Term Debt to Equity for the trailling 12 Months
KYTX Long Term Debt to Equity |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Equity TTM Growth |
212.15 % |
- |
- |
- |
- |
| Y / Y Long Term Debt TTM Growth |
- |
- |
- |
- |
- |
| Long Term Debt to Equity TTM |
- |
- |
- |
- |
- |
| Total Ranking TTM |
|
|
|
|
|
| Seq. Equity TTM Growth |
-10.84 % |
26.73 % |
43.59 % |
92.39 % |
- |
| Seq. Long Term Debt TTM Growth |
- |
- |
- |
- |
- |
On the trailing twelve months basis During the twelve months ending Q1 2025 Kyverna Therapeutics Inc did not have Long Term Debt . Long Term Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Biotechnology & Pharmaceuticals industry KYTX recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.
Explain Long Term Debt to Equity Ratio?
How much Long Term Debts KYTX´s has?
What are KYTX´s Equity?
| TTM Long Term Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Biotechnology & Pharmaceuticals Industry |
# |
| Healthcare Sector |
# |
| Within the Market |
# |
| trailing twelve months Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 | |
|
|
| Companies with similar Long Term Debt to Equity in the quarter ending Mar 31 2025, within Biotechnology & Pharmaceuticals Industry | Long Term Debt to Equity | Mar 31 2025 MRQ Long Term Debt | Mar 31 2025 MRQ Equity |
|
Date modified: 2025-05-15T04:35:49+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
